bpc-157 human evidence randomized clinical trial The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 – Prime Human Labs
Description
Weight Loss : Significant weight loss reported
Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD
There are also reports that rupture of the respiratory or intestinal epithelial barrier and weakening of other barriers, for example, the bloodbrain barrier or the vascular endothelial barrier, may facilitate the development of metabolic and autoimmune diseases [55, 81,82,83,84]
This has come up on a few other posts although Ive not heard it directly myself
